CRESCENT BIOPHARMA, INC. Increase (Decrease) in Prepaid Rent
CRESCENT BIOPHARMA, INC. (CBIO) reported Increase (Decrease) in Prepaid Rent of -$146.63 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidRent · last filed 2016-02-29
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for the quarter ending 2015-06-30 was $1.48K, a 94.12% decline year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for the quarter ending 2015-03-31 was $29.05K, a 14.02% increase year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for the quarter ending 2014-12-31 was $27.75K, a 14.23% increase year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for the quarter ending 2014-09-30 was $25.48K, a 16.18% increase year-over-year.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for fiscal 2015 was -$146.63K, a 241.08% decline from fiscal 2014.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for fiscal 2014 was $103.94K, a 14.82% increase from fiscal 2013.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for fiscal 2013 was $90.52K, a 85.39% increase from fiscal 2012.
- CRESCENT BIOPHARMA, INC. increase (decrease) in prepaid rent for fiscal 2012 was $48.83K.
| Period end | Increase (Decrease) in Prepaid Rent 3 month | Increase (Decrease) in Prepaid Rent 6 month | Increase (Decrease) in Prepaid Rent 9 month | Increase (Decrease) in Prepaid Rent 12 month | Increase (Decrease) in Prepaid Rent 130 month |
|---|---|---|---|---|---|
| 2015-12-31 | -$146.63K 10-K · filed 2016-02-29 | ||||
| 2015-06-30 | $1.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $30.53K 10-Q · filed 2015-08-06 | $58.28K derived: sum of 3 quarters · filed 2016-02-29 | $83.75K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2015-03-31 | $29.05K 10-Q · filed 2015-05-05 | $56.79K derived: sum of 2 quarters · filed 2016-02-29 | $82.27K derived: sum of 3 quarters · filed 2016-02-29 | $107.51K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-12-31 | $27.75K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $53.22K derived: sum of 2 quarters · filed 2016-02-29 | $78.46K derived: sum of 3 quarters · filed 2016-02-29 | $103.94K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $25.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $50.71K derived: sum of 2 quarters · filed 2015-08-06 | $76.19K 10-Q · filed 2014-10-31 | $100.48K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $25.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $50.71K 10-Q · filed 2015-08-06 | $75.00K derived: sum of 3 quarters · filed 2016-02-29 | $96.93K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $25.48K 10-Q · filed 2015-05-05 | $49.77K derived: sum of 2 quarters · filed 2016-02-29 | $71.69K derived: sum of 3 quarters · filed 2016-02-29 | $93.62K derived: sum of 4 quarters · filed 2016-02-29 | -$175.47K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $24.29K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $46.22K derived: sum of 2 quarters · filed 2016-02-29 | $68.14K derived: sum of 3 quarters · filed 2016-02-29 | $90.52K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $21.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $43.85K derived: sum of 2 quarters · filed 2014-10-31 | $66.23K 10-Q · filed 2014-10-31 | ||
| 2013-06-30 | $21.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $44.30K 10-Q · filed 2014-07-31 | |||
| 2013-03-31 | $22.37K 10-Q · filed 2014-05-09 | ||||
| 2012-12-31 | $48.83K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |